134 related articles for article (PubMed ID: 7907518)
1. The role of serotonin receptor subtypes in the behavioural effects of neuroleptic drugs. A paw test study in rats.
Ellenbroek BA; Prinssen EP; Cools AR
Eur J Neurosci; 1994 Jan; 6(1):1-8. PubMed ID: 7907518
[TBL] [Abstract][Full Text] [Related]
2. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
Naidu PS; Kulkarni SK
Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
Bagdy G; Kalogeras KT
Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
[TBL] [Abstract][Full Text] [Related]
5. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
6. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
Costall B; Naylor RJ
Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
8. Neonatal organizational effects of the 5-HT2 and 5-HT1A subsystems on adult behavior in the rat.
González MI; Albonetti E; Siddiqui A; Farabollini F; Wilson CA
Pharmacol Biochem Behav; 1996 May; 54(1):195-203. PubMed ID: 8728558
[TBL] [Abstract][Full Text] [Related]
9. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
Arnt J; Hyttel J
Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
[TBL] [Abstract][Full Text] [Related]
10. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors.
Backus LI; Sharp T; Grahame-Smith DG
Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051
[TBL] [Abstract][Full Text] [Related]
11. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
Kulikov AV; Kolpakov VG; Maslova GB; Kozintsev I; Popova NK
Psychopharmacology (Berl); 1994 Feb; 114(1):172-4. PubMed ID: 7846200
[TBL] [Abstract][Full Text] [Related]
12. Modulation of rat neocortical high-voltage spindle activity by 5-HT1/5-HT2 receptor subtype specific drugs.
Jäkälä P; Sirviö J; Koivisto E; Björklund M; Kaukua J; Riekkinen P
Eur J Pharmacol; 1995 Aug; 282(1-3):39-55. PubMed ID: 7498288
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
Bagdy G; Sved AF; Murphy DL; Szemeredi K
Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
[TBL] [Abstract][Full Text] [Related]
15. Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists.
Tremblay PO; Gervais J; Rouillard C
Eur J Neurosci; 1998 Nov; 10(11):3546-55. PubMed ID: 9824467
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
[TBL] [Abstract][Full Text] [Related]
17. Behavioural response to pharmacologic manipulation of serotonin receptors in the genetically dystonic hamster.
Richter A; Löscher W
Pharmacol Biochem Behav; 1995 Dec; 52(4):655-65. PubMed ID: 8587901
[TBL] [Abstract][Full Text] [Related]
18. Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: an in vivo electrophysiological study.
Bergqvist PB; Dong J; Blier P
Psychopharmacology (Berl); 1999 Mar; 143(1):89-96. PubMed ID: 10227084
[TBL] [Abstract][Full Text] [Related]
19. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
Ninan I; Kulkarni SK
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
[TBL] [Abstract][Full Text] [Related]
20. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
Riekkinen P
Eur J Pharmacol; 1994 Sep; 262(1-2):77-90. PubMed ID: 7813581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
